Edgewater has methodically developed our investment program since our founding, into a refined approach of demonstrated success.
The pharmaceutical industry is extremely complex and dynamic. Technology and regulatory changes are constantly occurring, making it a difficult space for private equity. Edgewater has been successful in this industry because we remain true to our investment parameters, acquiring businesses with:
- High, tangible barriers to competition;
- Niche markets; and
- Superior management teams (augmented our Operating Partners).